For: | Yu LM, Zhao KJ, Wang SS, Wang X, Lu B. Gas chromatography/mass spectrometry based metabolomic study in a murine model of irritable bowel syndrome. World J Gastroenterol 2018; 24(8): 894-904 [PMID: 29491683 DOI: 10.3748/wjg.v24.i8.894] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i8/894.htm |
Number | Citing Articles |
1 |
Ting-Ting Zhan, Zhi-Yu Dong, Li-Sha Yi, Yan Zhang, Hui-Hui Sun, Hai-Qin Zhang, Jun-Wen Wang, Ying Chen, Ying Huang, Shu-Chang Xu. Tandospirone prevents stress-induced anxiety-like behavior and visceral hypersensitivity by suppressing theta oscillation enhancement via 5-HT1A receptors in the anterior cingulate cortex in rats. Frontiers in Cellular Neuroscience 2022; 16 doi: 10.3389/fncel.2022.922750
|
2 |
Sean M. Bennet, Ammar H. Keshteli, Premysl Bercik, Karen L. Madsen, David Reed, Stephen J. Vanner. Application of metabolomics to the study of irritable bowel syndrome. Neurogastroenterology & Motility 2020; 32(6) doi: 10.1111/nmo.13884
|
3 |
Jing Xu, Qin-Feng Zhang, Jie Zheng, Bi-Feng Yuan, Yu-Qi Feng. Mass spectrometry-based fecal metabolome analysis. TrAC Trends in Analytical Chemistry 2019; 112: 161 doi: 10.1016/j.trac.2018.12.027
|
4 |
Lei-Min Yu, Min-Na Weng, Hui-Jun Chen, Wei Ye, Yi-Hong Fan. Study of efficacy and mechanism of low FODMAPs diet on diarrhea-type irritable bowel syndrome based on a gut microbiota-dependent metabolite. World Chinese Journal of Digestology 2021; 29(24): 1421 doi: 10.11569/wcjd.v29.i24.1421
|
5 |
Justine Ferey, Florent Marguet, Annie Laquerrière, Stéphane Marret, Isabelle Schmitz-Afonso, Soumeya Bekri, Carlos Afonso, Abdellah Tebani. A new optimization strategy for MALDI FTICR MS tissue analysis for untargeted metabolomics using experimental design and data modeling. Analytical and Bioanalytical Chemistry 2019; 411(17): 3891 doi: 10.1007/s00216-019-01863-6
|
6 |
Angxin Tong, Xiaojun Tang, Feng Zhang, Bin Wang. Predicting the redshift on the ultraviolet spectrum using the peak area method. Applied Optics 2020; 59(7): 1823 doi: 10.1364/AO.379554
|
7 |
Yanli Zhang, Huiting Zhu, Shiyu Du, Huifen Wang, Hui Li, Miao Wang, Bing Shao. Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI. Journal of Gastroenterology 2023; 58(11): 1124 doi: 10.1007/s00535-023-02030-6
|
8 |
Chinmayi Joshi, Vijay Kothari. Probiotics, Prebiotics, Synbiotics, and Postbiotics. 2023; : 29 doi: 10.1007/978-981-99-1463-0_2
|
9 |
Shanshan Nie, Yuhang Zhao, Xinjian Qiu, Wenbo Wang, Ye Yao, Min Yi, Dongsheng Wang. Metabolomic Study on Nude Mice Models of Gastric Cancer Treated with Modified Si Jun Zi Tang via HILIC UHPLC-Q-TOF/MS Analysis. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/3817879
|
10 |
Lesha Pretorius, Carine Smith. The trace aminergic system: a gender-sensitive therapeutic target for IBS?. Journal of Biomedical Science 2020; 27(1) doi: 10.1186/s12929-020-00688-1
|
11 |
Ying Gao, Peilun Ding, Junmin Wang, Caiyun Zhang, Guang Ji, Tao Wu. Application of metabolomics in irritable bowel syndrome in recent 5 years. International Immunopharmacology 2023; 124: 110776 doi: 10.1016/j.intimp.2023.110776
|
12 |
Yue Hu, Fang Chen, Haiyong Ye, Bin Lu. Integrative analysis of the gut microbiome and metabolome in a rat model with stress induced irritable bowel syndrome. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-97083-z
|
13 |
Bin-Bin Tang, Cheng-Xia Su, Na Wen, Qian Zhang, Jian-Hui Chen, Bin-Bin Liu, Yi-Qing Wang, Chao-Qun Huang, Yun-Lian Hu. FMT and TCM to treat diarrhoeal irritable bowel syndrome with induced spleen deficiency syndrome- microbiomic and metabolomic insights. BMC Microbiology 2024; 24(1) doi: 10.1186/s12866-024-03592-y
|
14 |
Jae Soung Lee, Seok‐Young Kim, Yoon Shik Chun, Young‐Jin Chun, Seung Yong Shin, Chang Hwan Choi, Hyung‐Kyoon Choi. Characteristics of fecal metabolic profiles in patients with irritable bowel syndrome with predominant diarrhea investigated using 1H‐NMR coupled with multivariate statistical analysis. Neurogastroenterology & Motility 2020; 32(6) doi: 10.1111/nmo.13830
|
15 |
Lei-Min Yu, Li-Qi Mao, Chun-Yan Wu, Wei Ye, Xi Wang. Chlorogenic acid improves intestinal barrier function by downregulating CD14 to inhibit the NF-κB signaling pathway. Journal of Functional Foods 2021; 85: 104640 doi: 10.1016/j.jff.2021.104640
|
16 |
P. Rodríguez-Hernández, M. J. Cardador, L. Arce, V. Rodríguez-Estévez. Analytical Tools for Disease Diagnosis in Animals via Fecal Volatilome. Critical Reviews in Analytical Chemistry 2022; 52(5): 917 doi: 10.1080/10408347.2020.1843130
|
17 |
Shanping Wang, Jiandong Huang, Fei Liu, Keai Sinn Tan, Liangjun Deng, Yue Lin, Wen Tan. Isosteviol Sodium Exerts Anti-Colitic Effects on BALB/c Mice with Dextran Sodium Sulfate-Induced Colitis Through Metabolic Reprogramming and Immune Response Modulation. Journal of Inflammation Research 2021; : 7107 doi: 10.2147/JIR.S344990
|
18 |
Joseph S. Miller, Luis Rodriguez-Saona, Kevin V. Hackshaw. Metabolomics in Central Sensitivity Syndromes. Metabolites 2020; 10(4): 164 doi: 10.3390/metabo10040164
|
19 |
Shengtao Zhu, Si Liu, Hengcun Li, Zheng Zhang, Qian Zhang, Lei Chen, Yu Zhao, Yang Chen, Junchao Gu, Li Min, Shutian Zhang. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome. Frontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00346
|
20 |
Xiaojiao Chen, Ting Lu, Xiaoxiao Wang, Xian Sun, Junqiang Zhang, Kun Zhou, Xiaoming Ji, Rongli Sun, Xinru Wang, Minjian Chen, Xiufeng Ling. Metabolic alterations associated with polycystic ovary syndrome: A UPLC Q-Exactive based metabolomic study. Clinica Chimica Acta 2020; 502: 280 doi: 10.1016/j.cca.2019.11.016
|
21 |
Yangwenshan Ou, Shanbin Chen, Fazheng Ren, Ming Zhang, Shaoyang Ge, Huiyuan Guo, Hao Zhang, Liang Zhao. Lactobacillus casei Strain Shirota Alleviates Constipation in Adults by Increasing the Pipecolinic Acid Level in the Gut. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.00324
|
22 |
Jinjoo Kim, Kumsun Cho, Joo Sung Kim, Hyun Chae Jung, Bumsik Kim, Myeong Soo Park, Geun Eog Ji, Joo-Youn Cho, Kyoung Sup Hong. Probiotic treatment induced change of inflammation related metabolites in IBS-D patients/double-blind, randomized, placebo-controlled trial. Food Science and Biotechnology 2020; 29(6): 837 doi: 10.1007/s10068-019-00717-2
|
23 |
Tong Liu, Xiang Gu, Li-Xiang Li, Ming Li, Bing Li, Xiao Cui, Xiu-li Zuo. Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients. BMC Microbiology 2020; 20(1) doi: 10.1186/s12866-020-01841-4
|
24 |
Zhixing He, Huinan Chen, Ying Chen, Xiaohui Sun, Fuhai Qiu, Yiwu Qiu, Chengping Wen, Yingying Mao, Ding Ye. Selenium deficiency induces irritable bowel syndrome: Analysis of UK Biobank data and experimental studies in mice. Ecotoxicology and Environmental Safety 2024; 281: 116604 doi: 10.1016/j.ecoenv.2024.116604
|
25 |
Roxana Cojocariu, Alin Ciobica, Ioana-Miruna Balmus, Samson Guenne, Anca Trifan, Carol Stanciu, Luminita Hrițcu, Radu Lefter. Antioxidant Capacity and Behavioral Relevance of a Polyphenolic Extract of Chrysanthellum americanum in a Rat Model of Irritable Bowel Syndrome. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/3492767
|
26 |
Michael X. Chen, San-Yuan Wang, Ching-Hua Kuo, I-Lin Tsai. Metabolome analysis for investigating host-gut microbiota interactions. Journal of the Formosan Medical Association 2019; 118: S10 doi: 10.1016/j.jfma.2018.09.007
|
27 |
Junchen Li, Huantian Cui, Yuzi Cai, Jin Lin, Xin Song, Zijun Zhou, Wantao Xiong, Huifang Zhou, Yuhong Bian, Li Wang. Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01110
|
28 |
Shuai Guo, Teng Ma, Lai-Yu Kwok, Keyu Quan, Bohai Li, Huan Wang, Heping Zhang, Bilige Menghe, Yongfu Chen. Effects of postbiotics on chronic diarrhea in young adults: a randomized, double-blind, placebo-controlled crossover trial assessing clinical symptoms, gut microbiota, and metabolite profiles. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2395092
|
29 |
Yaping Shao, Weidong Le. Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease. Molecular Neurodegeneration 2019; 14(1) doi: 10.1186/s13024-018-0304-2
|
30 |
Atul Rajkumar Chavan, Ashish Kumar Singh, Rakesh Kumar Gupta, Suraj Prabhakarrao Nakhate, Bhagyashri Jagdishprasad Poddar, Vaibhav Vilasrao Gujar, Hemant J. Purohit, Anshuman Arun Khardenavis. Recent trends in the biotechnology of functional non-digestible oligosaccharides with prebiotic potential. Biotechnology and Genetic Engineering Reviews 2023; 39(2): 465 doi: 10.1080/02648725.2022.2152627
|
31 |
He Zhu, Xi Xiao, Yuna Chai, Detang Li, Xue Yan, Hongmei Tang. MiRNA-29a modulates visceral hyperalgesia in irritable bowel syndrome by targeting HTR7. Biochemical and Biophysical Research Communications 2019; 511(3): 671 doi: 10.1016/j.bbrc.2019.02.126
|
32 |
Eugene Huh, Jin Gyu Choi, Mee Youn Lee, Jin Hee Kim, Yujin Choi, In Gyoung Ju, Hyeyoon Eo, Myoung Gyu Park, Dong-Hyun Kim, Hi-Joon Park, Choong Hwan Lee, Myung Sook Oh. Peripheral metabolic alterations associated with pathological manifestations of Parkinson’s disease in gut-brain axis-based mouse model. Frontiers in Molecular Neuroscience 2023; 16 doi: 10.3389/fnmol.2023.1201073
|
33 |
Shreyasi Sarkar, Mark D. Berry. Involvement of Organic Cation Transporter 2 and a Na+-dependent active transporter in p-tyramine transport across Caco-2 intestinal cells. Life Sciences 2020; 253: 117696 doi: 10.1016/j.lfs.2020.117696
|